Bennett Capital Partners, LLC

About The Fund

Bennett Capital Partners, LLC, operating under the brand DRI Healthcare, is a venture capital firm specializing in equity investments. With its headquarters located at 100 King St. West Suite 7250, PO Box 62, Toronto, Ontario, M5X 1B1, Canada, the firm has positioned itself as a pioneer in the field of pharmaceutical royalty monetization. Their investment thesis is centered around building a diversified portfolio of interests in medicines, with a particular focus on treatments that effectively address unmet medical needs. They pride themselves on actively sourcing royalty streams on medically necessary products that are protected by long-term patents and promise high growth potential. DRI Healthcare's strategy involves providing tailored offerings to both investors and innovators, positioning themselves as a best-in-class partner with multiple repeat deal partners. They aim to offer unique, creative, and flexible structures to meet counterparty needs. Their portfolio strategy encompasses not just current products but also legacy products and partnerships in innovation, advocating for a diversified portfolio of interests across multiple therapeutic areas. For investors, DRI Healthcare offers favourable exposure through a diversified, risk-mitigated portfolio of therapeutic assets aimed at generating attractive returns and significant growth potential. Their approach to smart capital allocation involves acquiring dependable, patent-protected cash flow streams derived from the sales of important drugs. Additionally, DRI Healthcare is committed to environmental, social, and governance (ESG) principles and provides comprehensive investor support, including stock quotes, news events, presentations, financials, analyst coverage, investor FAQ, and tax information. DRI Healthcare also emphasizes its responsibility and values, supporting a culture of teamwork and accountability across their offices in Toronto, New York, and New Jersey.